autologous cell
An autologous cell is a cell taken from the patient's own body, then grown, treated, or returned to that same person. The word means 'self', and that is the whole point: because the cells already belong to you, your immune system recognises them as part of you and does not attack them. It is like repairing your house with bricks taken from your own back garden — a perfect match by definition.
In practice, a clinician collects cells from the patient — from blood, skin, fat, or bone marrow — and a lab multiplies them, sometimes edits or coaxes them into another cell type, then puts them back. Because the genetics are an exact match, there is no foreign-tissue rejection, the central obstacle that haunts most transplants. This self-to-self approach underpins several established and experimental cell therapies.
The trade-off is practicality. Each batch is custom-made for one person, which makes autologous cells slow to produce, expensive, and impossible to keep ready on a shelf in advance. If a patient is very sick, the weeks needed to grow their cells can be a real problem. So autologous cells win on safety from rejection but lose on speed and scale — the mirror image of donor-sourced cells.
In one approach, doctors collect a patient's own immune cells, a lab reprograms them to hunt the patient's cancer, and they are infused back — self-derived, so the body does not reject them.
Autologous cells avoid immune rejection because they are the patient's own, but are slow and costly to make one batch at a time.